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Arkadia regulates TGF-b signaling during renal
tubular epithelial to mesenchymal cell transition
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Transforming growth factor-b (TGF-b) signaling has been
linked with tubular epithelial to mesenchymal cell transition.
In this study, we examined the role of Arkadia, an E3
ubiquitin ligase that is critically required for TGF-b signaling
during epithelial to mesenchymal cell transition. We found
that when normal human renal tubular epithelial cells in
culture were stimulated with TGF-b1, which increased their
levels of Arkadia, Smurf2, TGF-b type I receptor (TbRI), and
Smad7 mRNA, but had low levels of Smad7 protein. When
these cells were preincubated with Arkadia siRNA (small
interfering RNA) and lactacystin (an inhibitor of proteasomal
degradation), the TGF-b1 induced expression of Smad7,
a-smooth muscle actin, and E-cadherin was partly reversed,
but the expression of TbRI protein and Smad7 mRNA was not
affected. In contrast, Smurf2 siRNA had no influence on the
expression of these targets. Our studies suggest that Arkadia
stimulates renal tubular epithelial to mesenchymal cell
transition through degradation of Smad7.
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Tubulointerstitial fibrosis is a final common feature of end-
stage renal damage in various types of kidney diseases,1 and
renal tubular epithelial to mesenchymal cell transition (EMT)
plays a key role in the process.2 Tubular EMT is a process in
which renal tubular epithelial cells lose their epithelial
phenotype and acquire new characteristic features of
mesenchyme, which includes disruption of polarized tubular
epithelial cell morphology, de novo a-smooth muscle actin
(a-SMA) expression and actin reorganization, loss of cell–cell
adhesions through downregulation of E-cadherin, destruc-
tion of basement membrane, and increased cell migration
and invasion.2,3 TGF-b1 is a multifunctional cytokine that
affects a variety of biological processes, including extra-
cellular matrix accumulation, differentiation, cell cycle, and
apoptosis.4 Extensive clinical and experimental studies have
suggested that TGF-b1 is the most potent inducer that is
capable of initiating and completing the EMT course.2
Previous studies reported that TGF-b1-induced Smad2
phosphorylation results in the transformation of tubular
epithelial cell into a myofibroblast phenotype with the loss of
E-cadherin and de novo expression of a-SMA, collagens, I, III
and IV in a normal rat tubular epithelial cell.5 Moreover,
overexpression of inhibitory Smad7 was found to abolish
Smad2 phosphorylation and tubular cell phenotypic conver-
sion.5 These results suggest that TGF-b1-induced EMT is
primarily dependent on the positive or negative regulation of
Smad signaling.6
Smad proteins are critical intracellular mediators in the
TGF-b signaling pathway. The process of TGF-b/Smad
signaling pathway activation is as follows: upon TGF-b
stimulation, the activated TbRI associates transiently with
R-Smads (Smad2 and Smad3) and also phosphorylates them.
Then the phosphorylated R-Smads dissociate from the
receptor, bind to Smad4, and translocate into the nucleus,
where such a complex controls the transcription of TGF-b
responsive genes together with additional DNA-binding
cofactors. In contrast with R-Smads, Smad7 prevents or
attenuates TGF-b signaling through multiple mechanisms,
including interaction with activated TbRI and prevention of
R-Smad phosphorylation.7,8
Fukasawa et al.9 demonstrated that significant immunos-
taining of Smad7 was noted in tubular epithelial cells in
sham-operated kidneys; however, immunoreactivity for
Smad7 was markedly decreased in unilateral ureteral
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obstruction (UUO) kidneys, and the finding was further
confirmed by western blot. Moreover, the expression of
Smad7 mRNA is gradually increased in obstructed kidneys
compared with sham-operated kidneys.9 In addition, Wang
et al.10 indicated that Smad7 protein was markedly decreased
in normal mesangial cells stimulated with high glucose
compared with the normal mesangial cells. Accumulative
evidence indicates that Smad7 protein in some tissue and
organ fibrosis is obviously lower than that of the normal
control,9,11–15 and also demonstrates that upregulated Smad7
protein expression by transfection of the Smad7 gene in vivo
and in vitro can reverse or block fibrogenesis.12,16 These
studies suggested that Smad7 plays a key role in the
regulation of Smad-mediated TGF-b signaling during
progression of EMT and fibrosis in various diseases. There-
fore, understanding the reasons for low levels of Smad7 in
fibrotic diseases is of significance in the progression of
treatment and prevention of fibrosis.
The levels of some cellular proteins are modulated
dynamically by the ubiquitin–proteasome degradation path-
way.17,18 Smad protein is also regulated by this degradation
pathway. E3 ubiquitin ligases, such as Arkadia and Smurfs,
are involved in the ubiquitin-dependent proteasomal degra-
dation of Smad7.19 Smad7 has been shown to function as an
adapter protein that recruits ubiquitin ligases, termed
Smurfs, to the TGF-b receptor complex to promote its
degradation through proteasomal pathways.20,21 In contrast
with Smurfs, Arkadia regulates the transcriptional activity of
TGF-b only through degradation of Smad7 but not that of
TGF-b receptors.19 Owing to the discrepancy of Arkadia and
Smurfs, they have distinct roles in amplification or inhibition
of TGF-b signaling. In view of Arkadia being of relative
specificity and uniqueness in degrading Smad7, the major
focus of this study is to understand the role of Arkadia and
Smad7 in the pathogenesis of tubular EMT.
RESULTS
Expression of a-SMA and E-cadherin in HKCs stimulated with
TGF-b1
Consistent with previous reports,5 our results also demons-
trated that the expression of a-SMA, a myofibroblast marker,
is increased in a time-dependent manner in HKCs (human
renal tubular epithelial cells) stimulated with TGF-b1
compared with control HKCs, whereas the expression levels
of E-cadherin, a molecule that plays a key role in maintaining
the integrity of epithelial cells and is regarded as an epithelial
marker, is decreased in HKCs stimulated with TGF-b1 in a
time-dependent manner compared with control HKCs
(Figure 1).
Expression of Smad7 mRNA and protein in HKCs stimulated
with TGF-b1
The expression levels of Smad7 protein between control
HKCs and HKCs stimulated with TGF-b1 were detected by
western blot. The results showed that the expression level of
Smad7 protein was moderate and persistent in control HKCs
and gradually, but significantly, decreased in a time-
dependent manner in HKCs stimulated with TGF-b1. To
investigate whether the reduction of Smad7 protein was the
result of downregulation of Smad7 mRNA, we analyzed the
mRNA expression of Smad7 by real-time reverse transcrip-
tion-PCR (real time RT-PCR). In contrast to the significant
decrease of Smad7 protein, the Smad7 mRNA expression was
increased in HKCs stimulated with TGF-b1 compared with
control HKCs. These results suggest that there could be some
materials degrading Smad7 protein during the renal tubular
EMT (Figure 2).
Increased expression of Arkadia, Smurf2, and TbRI in HKCs
stimulated with TGF-b1
The expression levels of Arkadia, Smurf2, and TbRI in
control HKCs and HKCs stimulated with TGF-b1 were
detected by western blot. The results showed that Arkadia,
Smurf2, and TbRI were expressed weakly in control HKCs;
however, the expressions of Arkadia, Smurf2, and TbRI
proteins were gradually increased in HKCs stimulated with
TGF-b1 (Figure 3).
Arkadia can interact with Smad7 in HKCs
To investigate the respective interaction of Arkadia with
Smad7 and TbRI in HKCs, cell lysates collected from control
HKCs and HKCs stimulated with TGF-b1 for 24 h were
immunoprecipitated by using anti-Smad7 or anti-TbRI,
followed by immunoblotting using the corresponding anti-
body. In HKCs stimulated with TGF-b1, the complex
composed of Arkadia–Smad7 and that of Smurf2–Smad7
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Figure 1 | Expression of a-SMA and E-cadherin in HKCs stimulated
with TGF-b1. (a) Western blot demonstrated that the expression of
a-SMA was increased in a time-dependent manner in HKCs
stimulated with TGF-b1 compared with control HKCs (0 h), whereas,
the expression of E-cadherin was decreased in HKCs stimulated with
TGF-b1 in a time-dependent manner compared with control HKCs
(0 h). (b) The ratios of a-SMA/b-actin and E-cadherin/b-actin in HKCs
stimulated with TGF-b1. Experiments were repeated three times with
similar results, and the data were expressed as the mean ratio±s.d.
*Po0.05 and **Po0.01 compared with control HKCs (0 h).
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were all noted. In addition, the complex composed of
Smurf2–TbRI was noted; however, no complex composed of
Arkadia and TbRI was detected. The present findings
indicated that Smad7 can interact with Arkadia or Smurf2,
and TbRI could interact with Smurf2 but not with Arkadia in
HKCs. Taken together with the previous results that TbRI
expression level was increased in HKCs stimulated with
TGF-b1, our findings suggest that the low expression of
Smad7 could be mainly attributed to the high expression of
Arkadia in HKCs stimulated with TGF-b1 (Figure 4).
Effects of Arkadia siRNA on the expression of Arkadia, TbRI,
Smad7, Arkadia mRNA, and Smad7 mRNA induced by TGF-b1
in HKCs
Western blot and real-time RT-PCR were performed on
HKCs that had been preincubated with or without Arkadia
siRNA and then stimulated with TGF-b1. The expression of
Arkadia protein and that of its mRNA in HKCs stimulated
with TGF-b1 were respectively inhibited by Arkadia siRNA
and lactacystin. In addition, Smad7 protein was increased in
HKCs stimulated with TGF-b1 in the presence of Arkadia
siRNA or lactacystin compared with HKCs stimulated with
TGF-b1. Similar to the control siRNA and sham plasmid,
Arkadia siRNA did not significantly affect the expression of
TbRI, but lactacystin inhibited the expression of TbRI
induced by TGF-b1 in HKCs. Both Arkadia siRNA and
lactacystin did not significantly affect the expression of
Smad7 mRNA in HKCs (Figure 5).
Effects of Smurf2 siRNA on the expression of Smurf2 and
Smad7 induced by TGF-b1 in HKCs
Western blot was performed on HKCs that had been
preincubated with or without Smurf2 siRNA and then
stimulated with TGF-b1. The expression of Smurf2 in HKCs
stimulated with TGF-b1 was inhibited by Smurf2 siRNA and
lactacystin, while control siRNA and sham plasmid did not
affect the expression of Smurf2. Similar to the control siRNA
and sham plasmid, Smad7 protein was not increased in HKCs
stimulated with TGF-b1 in the presence of Smurf2 siRNA
compared with HKCs stimulated with TGF-b1, while
lactacystin could increase the expression of Smad7 protein
in HKCs stimulated with TGF-b1 (Figure 6).
Effects of Arkadia siRNA on the expression of a-SMA and
E-cadherin induced by TGF-b1 in HKCs
Western blot was performed on HKCs that had been
preincubated with or without Arkadia siRNA and then
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Figure 2 | Expressions of Smad7 mRNA and protein in HKCs
stimulated with TGF-b1. (a) Western blot showed that the
expression of Smad7 protein was gradually decreased in HKCs
stimulated with TGF-b1 compared with control HKCs (0 h). (b) The
ratios of Smad7/b-actin in HKCs stimulated with TGF-b1. (c) Real-time
RT-PCR indicated that the Smad7 mRNA expression increased in HKCs
stimulated with TGF-b1 compared with control HKCs (0 h). The ratios
of Smad7 mRNA/b-actin mRNA in HKCs stimulated with TGF-b1 are
shown. Experiments were repeated three times with similar results,
and the data were expressed as the mean ratio±s.d. **Po0.01
compared with control HKCs (0 h).
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Figure 3 | Expression of Arkadia, Smurf2, and TbRI in HKCs
stimulated with TGF-b1. (a) Western blot showed that Arkadia
expression increased in a time-dependent manner in HKCs stimulated
with TGF-b1 compared with control HKCs (0 h). Similarly, Smurf2 and
TbRI were expressed weakly in control HKCs, but were gradually
increased in HKCs stimulated with TGF-b1. (b) The ratios of Arkadia/
b-actin (Smurf2/b-actin, TbRI/b-actin) in HKCs stimulated with TGF-b1.
Experiments were repeated three times with similar results, and the
data were expressed as the mean ratio±s.d. **Po0.01 compared
with the control HKCs (0 h).
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stimulated with TGF-b1. The expression of a-SMA was
decreased in HKCs stimulated with TGF-b1 in the presence of
Arkadia siRNA or lactacystin compared with HKCs stimu-
lated with TGF-b1, but the expression of E-cadherin was
elevated in HKCs stimulated with TGF-b1 in the presence of
Arkadia siRNA or lactacystin compared with HKCs stimu-
lated with TGF-b1. However, the expression of a-SMA and
E-cadherin was not affected by control siRNA and sham
vector (Figure 7).
DISCUSSION
Accumulating evidence suggests that tubular EMT plays a
pathogenic role in renal tubulointerstitial fibrosis,2 and TGF-b
/Smad signaling is a central pathway in regulating tubular
EMT.6 Smad7, an intracellular antagonist for TGF-b signal-
ing, associates with the activated TGF-b receptor, which
interferes with the activation of Smad2 and Smad3 by
preventing their interaction with activated TGF-b receptors
and consequent phosphorylation.7,8 Therefore, it is concei-
vable that the cellular level of Smad7 is a major determinant
of TGF-b responses, which could regulate the intensity
and duration of TGF-b signals. Recent studies have showed
that the ubiquitin–proteasome pathway has an important
influence on TGF-b signaling through regulating Smads
degradation, including Smad7.12 E3 ubiquitin ligases, such as
Arkadia and Smurfs, play an important role in the process of
degradation.
Smad7 has been shown to function as an adapter protein
that recruits Arkadia or links TGF-b receptor to Smurfs,
resulting in Smad7 or Smad7–TGF-b receptor complex
degradation through proteasomal pathways.19–21 The rela-
tionship between Smurfs and Smad7 has been investigated in
some diseased models, such as renal fibrosis and scleroderma.
Asano et al.22 reported that scleroderma fibroblasts exhibited
increased Smad7 and TbRI levels compared with normal
fibroblasts, but there was no significant difference in Smurfs
levels between normal and scleroderma fibroblasts, and the
transiently overexpressed Smurfs did not affect TbRI protein
levels in scleroderma fibroblasts. These results suggested that
Smurf2–Smad7–TbRI-mediated negative regulation of TGF-b
signaling was impaired, which might contribute to main-
taining the autocrine TGF-b loop in scleroderma;22 other-
wise, Smurf2 should lead to inhibition of TGF-b signaling
through degradation of TbRI and Smad7. Fukasawa et al.9
reported low expression levels of Smad7 protein, but high
levels of Smad7 mRNA, and both degradation and ubiqui-
tination of Smad7 protein were markedly increased in UUO
kidneys, in which both Smurf2 and Smurf1 expression were
increased, and Smurf2 was more evident than Smurf1 in the
process of Smad7 ubiquitination. The findings suggested that
accelerated degradation of Smad7 by the ubiquitin–protea-
some pathway, which could be mediated by Smurf proteins,
contributed to the reduction of Smad7 in fibrotic UUO
kidneys.9 However, the study only demonstrated the effect of
Smurfs on Smad7, but the expression of TbRI and the
relationship between Smurfs and TbRI had not been
investigated. Taken together, it seems that Smurfs have
distinct roles in amplification or inhibition of TGF-b
signaling in various disease processes.
In agreement with the study by Fukasawa,9 we also
demonstrated a significant increase of Smurf2 protein and
Smad7 mRNA expression levels and a dramatic reduction of
Smad7 protein in UUO kidneys, moreover, our results also
indicated that the expression of Arkadia and TbRI proteins
was increased in UUO kidneys.23 These results seem to be
contradictory to the notion that high expression levels of
Smurf2 will result in the degradation of TGF-b receptor and
Smad7.
In contrast with Smurfs, it is very important that Arkadia
is not recruited to TGF-b receptors and does not induce their
degradation.19 In other words, Arkadia regulates the
transcriptional activity of TGF-b signaling through degrada-
tion of Smad7 but not through that of TGF-b receptors.19 In
accordance with the in vivo studies.9,23 We demonstrated a
significant increase of Smad7 mRNA expression levels and a
reduction of Smad7 protein in HKCs treated with TGF-b1. In
addition, our results also indicated that the expression of
Arkadia, Smurf2, and TbRI proteins was increased in HKCs
treated with TGF-b1. Moreover, immunoprecipitation analy-
sis indicated that Smurf2 could interact with Smad7 and
TbRI, and Arkadia only interacts with Samd7 but not with
TGF-β1 (0 h) TGF-β1 (24 h)
IgG
106 KDa
92 KDa
53 KDa
47 KDa
106 KDa
92 KDa
47 KDa
53 KDa
IB; Arkadia
IB; Smurf2
IB; Smad7
IB; TβRI
IB; Arkadia
IB; Smurf2
IB; TβRI
IB; Smad7
IgGIP;
IP;
Smad7Smad7
IgGIgG TβRITβRI
TGF-β1 (0 h) TGF-β1 (24 h)
Figure 4 | Arkadia can interact with Smad7 in HKCs. Cell lysates
collected from HKCs stimulated with TGF-b1 for 0 h (control HKCs)
and for 24 h. (a) Cell lysates were subjected to Smad7
immunoprecipitation (IP), followed by Arkadia, Smurf2, and TbRI
immunoblotting (IB). In HKCs stimulated with TGF-b1, the
Smad7–Arkadia, Smad7–TbRI, and Smad7–Smurf2 complexes were
noted. (b) Cell lysates were subjected to TbRI immunoprecipitation,
followed by Arkadia, Smurf2, and Smad7 immunoblotting. In HKCs
stimulated with TGF-b1, the TbRI–Smad7 and TbRI–Smurf2 complexes
were noted; however, no complex composed of TbRI and Arkadia
was detected. Representative data of three independent experiments
are shown.
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TbRI in HKCs. In view of the findings mentioned above, we
speculated that the reduction of Smad7 is mainly mediated
by Arkadia but not by Smurf2.
To test this presumption, we knocked down the expression
of endogenous Arkadia and Smurf2 by using siRNA. The
results indicate that Arkadia siRNA increase smad7 protein
expression in the HKCs stimulated with TGF-b1, but Smurf2
siRNA dose not affect Smad7 protein expression. There was
no significant difference in the expression of Smad7 mRNA
and TbRI protein between the HKCs stimulated with TGF-b1
and the HKCs stimulated with TGF-b1 in the presence of
Arkadia siRNA. The result suggested that Arkadia did not
affect TbRI levels and also ruled out transcriptional
suppression of the expression of Smad7 gene in HKCs.
Similar to Arkadia siRNA, smad7 protein expression in the
HKCs stimulated with TGF-b1 was elevated by lactacystin.
These results further confirmed that degradation of Smad7 by
the ubiquition–proteasome pathway, which could be mainly
attributed to Arkadia, contributes to the reduction of Smad7
protein in HKCs stimulated with TGF-b1.
Because the process of tubular EMT can be blocked
by overexpression of Smad7,5 and because of the tight
association between Arkadia and Smad7, we further in-
vestigated the effect of Arkadia siRNA on tubular EMT
induced by TGF-b1. In agreement with Li’s study,
5 we
also demonstrated that there was a significant increase of
a-SMA expression and a loss of E-cadherin in HKCs
stimulated with TGF-b1 compared with the control HKCs
in a time-dependent manner, which suggested that renal
tubular cells lost their epithelial phenotype and acquired
new characteristic features of mesenchyme. Subsequently,
a-SMA expression was decreased and E-cadherin expression
was increased in HKCs stimulated with TGF-b1 in the
presence of Arkadia siRNA compared with the HKCs
stimulated with TGF-b1. These results suggest that Arkadia
siRNA is able to relieve the degree of renal EMT through
upregulated Smad7 expression; in other words, Arkadia
could positively contribute to renal tubular EMT through
degradation of Smad7.
MATERIALS AND METHODS
Cell culture
Normal HKCs were grown in a 5% CO2 atmosphere at 371C in 1640
medium containing 10% fetal bovine serum in six-well plastic
plates. A recombinant human TGF-b1 (R&D Systems) at concentra-
tions of 5 ng ml1 was added into the cell culture for periods of 0, 6,
12, 24, 48, and 72 h, then the expressions of a-SMA, E-cadherin,
Smad7, Smad7 mRNA, Arkadia, Arkadia mRNA, Smurf2, and TbRI
in HKCs stimulated with TGF-b1 were detected by western blot
TGF-β1
Arkadia siRNA
+
+
+
++
+
+
+
+
−
− − − −
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
Control siRNA
Sham vector
Lactacystin
106 KDa
53 KDa
47 KDa
43 KDa
Arkadia
Ar
ka
di
a,
 T
βR
I, 
Sm
ad
7/
β-a
ct
in
β-Actin
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0
1
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗
∗∗∗∗
∗
2 3 4 5 6
TβRI
Smad7
Arkadia TβRI Smad7
Ar
ka
di
a 
m
RN
A
/β-
a
ct
in
  
m
R
N
A
Arkadia mRNA
Sm
ad
7 
m
RN
A
/β-
a
ct
in
 
 
m
R
N
A
Smad7 mRNA
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
1 2 3 4 5 61 2 3 4 5 6
∗∗
∗∗
∗∗
∗∗ ∗∗
∗∗
∗∗ ∗∗ ∗∗
∗∗
a b
c d
Figure 5 | Effects of Arkadia siRNA on the expression of Arkadia, TbRI, Smad7, Arkadia mRNA, and Smad7 mRNA induced by TGF-b1 in
HKCs. (a) Western blot indicated that the expression of Arkadia in HKCs stimulated with TGF-b1 was inhibited by Arkadia siRNA or lactacystin,
while control siRNA and sham vector did not affect the expression of Arkadia. Smad7 protein was increased in HKCs stimulated with TGF-b1 in
the presence of Arkadia siRNA compared with HKCs stimulated with TGF-b1. Similar to the control siRNA and sham vector, Arkadia siRNA did
not significantly affect the expression of TbRI, but the expression of TbRI in HKCs stimulated with TGF-b1 was inhibited by lactacystin. (b) The
ratios of Arkadia/b-actin (TbRI/b-actin and Smad7/b-actin) in the cells. (c) Total RNA was subjected to real-time RT-PCR for measurement of
Smad7 mRNA and b-actin mRNA levels. Similar to the control siRNA and sham vector, neither Arkadia siRNA nor lactacystin significantly
affected the expression of Smad7 mRNA in HKCs stimulated with TGF-b1. Data are ratios of Smad7 mRNA/b-actin mRNA. (d) Real-time RT-PCR
indicated that the expression of Arkadia mRNA in HKCs stimulated with TGF-b1 was inhibited by Arkadia siRNA or lactacystin, while control
siRNA and sham vector did not affect the expression of Arkadia. Data are ratios of Arkadia mRNA/b-actin mRNA. Lane 1: control HKCs; lane 2:
HKCs treated with TGF-b1; lane 3: HKCs treated with TGF-b1 in the presence of Arkadia siRNA; lane 4: HKCs treated with TGF-b1 in the presence
of control siRNA; lane 5: HKCs treated with TGF-b1 in the presence of sham vector; lane 6: HKCs treated with TGF-b1 in the presence of
lactacystin. Experiments were repeated three times with similar results, and the data were expressed as the mean ratio±s.d. *Po0.05 and
**Po0.01 compared with the control HKCs; mmPo0.01 compared with the HKCs treated with TGF-b1.
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and real-time RT-PCR. Subsequently, HKCs were stimulated with
TGF-b1 for 24 h in the presence or absence of the siRNA against
Arkadia/Smurf2 (Genesil Biotechnology, Wuhan, China) (2 mg ml1,
24 h) and lactacystin (Sigma, St Louis, MO, USA) (10 mM, 3 h) for
detecting the target material mentioned above.
RNA interference
The siRNA oligonucleotide sequences against Arkadia (GI: 37595552)
and Smurf2 (GI: 56550041) were synthesized by Genesil Biotechnology.
Arkadia siRNA: 50-GATCCGTCTCTGTAAGACATTCCCTTCAAGA
CGGGGAATGTCTTACAGAGACTTTTTTGAATTCA-30, 30-GCAG
AGACATTCTGTAAGGGAAGTTCTGCCCCTTACAGAATGTCTCT
GAAAAAACTTAAGTTCGA-50; Smurf2 siRNA: 50-GATCCGGTGG
TGGTTGATGGATCTTTCAAGACGAGATCCATCAACCACCACCT
TTTTTGTCGACA-30, 30-GCCACCACCAACTACCTAGAAAGTTCT
GCTCTAGGTAGTTGGTGGTGGAAAAAACAGCTGTTCGA-50; ne-
gative control siRNA: 50-GATCCGACTTCATAAGGCGCATGCT
TCAAGACGGCATGCGCCTTATGAAGTCTTTTTTGTCGACA-30,
30-GCTGAAGTATTCCGCGTACGAAGTTCTGCCGTACGCGGAAT
ACTTCAGAAAAAACAGCTGTTCGA-50. The siRNAs (2mg ml1)
were introduced into cells using the Lipofectamine 2000 reagent
(Invitrogen, Grand Island, NY, USA) according to the manufac-
turer’s instructions.
Western blot
Cells were lysed with Nonidet P-40 (NP-40) lysis buffer (20 mM Tris-
HCl pH 7.5, 150 mM NaCl, and 1% NP-40) in the presence of
protease inhibitors at 41C. After incubation for 30 min, the lysates
were centrifuged at 41C for 10 min at 10 000 g. The protein
concentrations of the lysates were measured with a DC protein
assay reagent (Bio-Rad, CA, USA). Soluble lysates were boiled for
5 min with 2 SDS sample buffer. Samples (40 mg per lane) from the
total protein fraction were loaded and separated by SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE). Protein was transferred
to polyvinylidene difluoride membranes (Pharmacia Corporation,
NJ, USA) and probed with primary antibodies against human
Arkadia (goat polyclonal antibody, Santa Cruz Biotechnology,
Santa Cruz, CA, USA), Smurf2 (goat polyclonal antibody, Santa
Cruz Biotechnology), Smad7 (rabbit polyclonal antibody, Santa
Cruz Biotechnology), TbRI (rabbit polyclonal antibody, Santa Cruz
Biotechnology), E-cadherin (mouse monoclonal antibody, BD
Biotechnology, NC, USA), a-SMA (mouse monoclonal antibody,
Sigma), and b-actin (mouse monoclonal antibody, Sigma). The
primary antibodies that bound to the target proteins were detected
using horseradish peroxidase-conjugated anti-rabbit IgG (Promega,
Madison, WI, USA), anti-goat IgG (Promega), or anti-mouse IgG
(Cortex Biochem, San Leandro, CA, USA), as appropriate. The
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Figure 6 | Effects of Smurf2 siRNA on the expression of Smurf2
and Smad7 induced by TGF-b1 in HKCs. (a) Western blot indicated
that the expression of Smurf2 in HKCs stimulated with TGF-b1 was
inhibited by Smurf2 siRNA or lactacystin, while control siRNA and
sham vector did not affect the expression of Smurf2. Similar to the
control siRNA and sham vector, Smad7 protein was not increased in
HKCs stimulated with TGF-b1 in the presence of Smurf2 siRNA
compared with HKCs stimulated with TGF-b1, while lactacystin
could increase the expression of Smad7 protein in HKCs stimulated
with TGF-b1. (b) The ratios of Smurf2/b-actin (Smad7/b-actin)
in the cells. Lane 1:control HKCs; lane 2: HKCs treated with TGF-b1;
lane 3: HKCs treated with TGF-b1 in the presence of sham
vector; lane 4: HKCs treated with TGF-b1 in the presence of control
siRNA; lane 5: HKCs treated with TGF-b1 in the presence of
Arkadia siRNA; lane 6: HKCs treated with TGF-b1 in the presence of
lactacystin. Experiments were repeated three times with similar
results, and the data were expressed as the mean ratio±s.d.
**Po0.01 compared with the control HKCs; mPo0.05 and mmPo0.01
compared with the HKCs treated with TGF-b1.
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Figure 7 | Effects of Arkadia siRNA on the expression of
E-cadherin and a-SMA induced by TGF-b1 in HKCs. (a) Western
blot indicated that the expression of a-SMA was decreased in HKCs
stimulated with TGF-b1 in the presence of Arkadia siRNA or
lactacystin compared with HKCs stimulated with TGF-b1. However,
the expression of E-cadherin was elevated in HKCs stimulated with
TGF-b1 in the presence of Arkadia siRNA or lactacystin compared with
HKCs stimulated with TGF-b1 (b) The ratios of a-SMA/b-actin and
E-cadherin/b-actin in the cells. Lane 1:control HKCs; lane 2: HKCs
treated with TGF-b1; lane 3: HKCs treated with TGF-b1 in the presence
of Arkadia siRNA; lane 4: HKCs treated with TGF-b1 in the presence of
control siRNA; lane 5: HKCs treated with TGF-b1 in the presence of
sham vector; lane 6: HKCs treated with TGF-b1 in the presence of
lactacystin. Experiments were repeated three times with similar
results, and the data were expressed as the mean ratio±s.d.
**Po0.01 compared with the control HKCs; mmPo0.01 compared
with the HKCs treated with TGF-b1.
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antibodies were visualized with enhanced chemiluminescent detec-
tion (Pierce Biotechnology, Rockford, ZL, USA).
Immunoprecipitation
The cell lysates were preincubated with 2 mg of anti-Smad7 antibody
or anti-TbRI antibody and 50 ml of protein G-Sepharose beads at
41C. Immunoprecipitated proteins were washed three times with
cold lysis buffer and then separated by SDS-PAGE for immunode-
tection of associated proteins in the complex. The lysates
preincubated with anti-rabbit IgG instead of anti-Smad7 antibody
or anti-TbRI antibody were used as negative controls.
Real-time RT-PCR
Total RNA was extracted using Trizol (Invitrogen). Reverse
transcription of the RNA was performed using a first-strand cDNA
synthesis kit (Promega). The PCR with SYBR Green PCR Master
Mix (Takara, Shiga, Japan) was used to analyze Arkadia mRNA and
Smad7 mRNA. Real-time PCR analysis was performed using the ABI
PRISM 7900-HT Sequence Detection System (Applied Biosystems,
Foster City, CA, USA). The primer sequences used were as follows:
human Arkadia: forward 50-CCACATAGGATGCACCCAAAC-30,
reverse 50-AATTCCCAGTTCCCAGGCA-30; human Smad7: forward
50-CCTTAGCCGACTCTGCGAACTA-30, reverse 50-CCAGATAATT
CGTTCCCCCTGT-30; and human b-actin: forward 50 -TGGGTCAG
AAGGACTCCTATG-30 reverse 50-CAGGCAGCTCATAGCTCTTCT-30.
PCR amplification cycles were carried out under the following
conditions: initial denaturation at 95 1C for 30 s, followed by 40
amplification cycles of 15 s at 95 1C and 20 s at 59 or 60 1C. The
fluorescent product was detected at the end of each cycle. Product
specificity was confirmed in initial experiments by agarose gel
electrophoresis and routinely by melting-curve analysis. Real-time
PCR data were analyzed according to the manufacturer’s instructions.
Statistical analysis
Data are presented as means±s.d. Statistical analysis was performed
by ANOVA, and significance was defined as Po0.05.
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